Difference between revisions of "Team:Edinburgh OG/Notebook"

Line 30: Line 30:
 
           <p class="team_designation">MSc Synthetic Biology &amp; Biotechnology</p>
 
           <p class="team_designation">MSc Synthetic Biology &amp; Biotechnology</p>
 
           <p class="team_text">Engineering <i>E. coli</i> to create our mock pathogen testing platform, and engineering the lytic T7 phage.</p>
 
           <p class="team_text">Engineering <i>E. coli</i> to create our mock pathogen testing platform, and engineering the lytic T7 phage.</p>
−
           <p class="social-icons">
+
           <p class="social-icons" style="text-align:center;">
 +
            <a href="https://www.facebook.com/filippo.abbondanza" class="facebook" target="_blank"><i class="ion-document"></i> Notebook</a>
 
           </p>
 
           </p>
 
         </div>
 
         </div>
Line 42: Line 43:
 
           <p class="team_designation">MSc Biochemistry</p>
 
           <p class="team_designation">MSc Biochemistry</p>
 
           <p class="team_text">Engineering the lysogenic P1 phage with a CRISPR system to target resistance gene fragments.</p>
 
           <p class="team_text">Engineering the lysogenic P1 phage with a CRISPR system to target resistance gene fragments.</p>
−
           <p class="social-icons">
+
           <p class="social-icons" style="text-align:center;">
−
             <a href="https://www.facebook.com/y.q.heybd" class="facebook" target="_blank"><i class="ion-social-facebook-outline"></i></a>
+
             <a href="https://www.facebook.com/filippo.abbondanza" class="facebook" target="_blank"><i class="ion-document"></i> Notebook</a>
−
 
+
 
           </p>
 
           </p>
 
         </div>
 
         </div>
Line 55: Line 55:
 
             <p class="team_designation">MSc Biotechnology</p>
 
             <p class="team_designation">MSc Biotechnology</p>
 
             <p class="team_text">Engineering the lysogenic lambda phage with a CRISPR system to target resistance gene fragments.</p>
 
             <p class="team_text">Engineering the lysogenic lambda phage with a CRISPR system to target resistance gene fragments.</p>
−
             <p class="social-icons">
+
             <p class="social-icons" style="text-align:center;">
−
               <a href="https://www.facebook.com/profile.php?id=100012772305809" class="facebook" target="_blank"><i class="ion-social-facebook-outline"></i></a>
+
               <a href="https://www.facebook.com/filippo.abbondanza" class="facebook" target="_blank"><i class="ion-document"></i> Notebook</a>
 
             </p>
 
             </p>
 
           </div>
 
           </div>
Line 70: Line 70:
 
             <p class="team_designation">MSc Synthetic Biology &amp; Biotechnology</p>
 
             <p class="team_designation">MSc Synthetic Biology &amp; Biotechnology</p>
 
             <p class="team_text">Engineering <i>E. coli</i> to create our mock pathogen testing platform and engineering the lytic T4 phage using BRED.</p>
 
             <p class="team_text">Engineering <i>E. coli</i> to create our mock pathogen testing platform and engineering the lytic T4 phage using BRED.</p>
−
             <p class="social-icons">
+
             <p class="social-icons" style="text-align:center;">
 +
              <a href="https://www.facebook.com/filippo.abbondanza" class="facebook" target="_blank"><i class="ion-document"></i> Notebook</a>
 
             </p>
 
             </p>
 
           </div>
 
           </div>
Line 82: Line 83:
 
             <p class="team_designation">MSc Biotechnology</p>
 
             <p class="team_designation">MSc Biotechnology</p>
 
             <p class="team_text">Engineering the lysogenic P1 phage with a CRISPR system to target resistance gene fragments.</p>
 
             <p class="team_text">Engineering the lysogenic P1 phage with a CRISPR system to target resistance gene fragments.</p>
−
             <p class="social-icons">
+
             <p class="social-icons" style="text-align:center;">
−
               <a href="https://www.facebook.com/profile.php?id=100004212933551" class="facebook" target="_blank"><i class="ion-social-facebook-outline"></i></a>
+
               <a href="https://www.facebook.com/filippo.abbondanza" class="facebook" target="_blank"><i class="ion-document"></i> Notebook</a>
 
             </p>
 
             </p>
 
           </div>
 
           </div>
Line 95: Line 96:
 
             <p class="team_designation">MSc Bioinformatics</p>
 
             <p class="team_designation">MSc Bioinformatics</p>
 
             <p class="team_text">Building a model of bacteria-phage interactions in two-step re-sensitisation combining both lysogenic and lytic phages.</p>
 
             <p class="team_text">Building a model of bacteria-phage interactions in two-step re-sensitisation combining both lysogenic and lytic phages.</p>
−
             <p class="social-icons">
+
             <p class="social-icons" style="text-align:center;">
−
               <a href="https://www.facebook.com/puzorjov" class="facebook" target="_blank"><i class="ion-social-facebook-outline"></i></a>
+
               <a href="https://www.facebook.com/filippo.abbondanza" class="facebook" target="_blank"><i class="ion-document"></i> Notebook</a>
−
              <a href="https://twitter.com/AntonPuzorjov" target="_blank"><i class="ion-social-twitter-outline"></i></a>
+
−
              <a href="https://www.linkedin.com/in/antonpuzorjov/" target="_blank"><i class="ion-social-linkedin-outline"></i></a>
+
 
             </p>
 
             </p>
 
           </div>
 
           </div>
Line 110: Line 109:
 
             <p class="team_designation">MSc Drug Discovery &amp; Translational Biology</p>
 
             <p class="team_designation">MSc Drug Discovery &amp; Translational Biology</p>
 
             <p class="team_text">Engineering the lysogenic phage P1 with a CRISPR system to target resistance gene fragments.</p>
 
             <p class="team_text">Engineering the lysogenic phage P1 with a CRISPR system to target resistance gene fragments.</p>
−
             <p class="social-icons">
+
             <p class="social-icons" style="text-align:center;">
−
               <a href="https://www.facebook.com/profile.php?id=100010921308790" class="facebook" target="_blank"><i class="ion-social-facebook-outline"></i></a>
+
               <a href="https://www.facebook.com/filippo.abbondanza" class="facebook" target="_blank"><i class="ion-document"></i> Notebook</a>
 
             </p>
 
             </p>
 
           </div>
 
           </div>
Line 126: Line 125:
 
             <p class="team_designation">MSc Synthetic Biology &amp; Biotechnology</p>
 
             <p class="team_designation">MSc Synthetic Biology &amp; Biotechnology</p>
 
             <p class="team_text">Engineering the lysogenic lambda phage with a CRISPR system to target resistance gene fragments.</p>
 
             <p class="team_text">Engineering the lysogenic lambda phage with a CRISPR system to target resistance gene fragments.</p>
−
             <p class="social-icons">
+
             <p class="social-icons" style="text-align:center;">
 +
              <a href="https://www.facebook.com/filippo.abbondanza" class="facebook" target="_blank"><i class="ion-document"></i> Notebook</a>
 
             </p>
 
             </p>
 
           </div>
 
           </div>

Revision as of 09:02, 28 October 2017

PhagED: a molecular toolkit to re-sensitise ESKAPE pathogens

NOTEBOOK

Filippo Abbondanza

MSc Synthetic Biology & Biotechnology

Engineering the lysogenic lambda phage with a CRISPR system to target resistance gene fragments.

Erin Corbett

MSc Synthetic Biology & Biotechnology

Engineering E. coli to create our mock pathogen testing platform, and engineering the lytic T7 phage.

Yunqi He

MSc Biochemistry

Engineering the lysogenic P1 phage with a CRISPR system to target resistance gene fragments.

Ti He

MSc Biotechnology

Engineering the lysogenic lambda phage with a CRISPR system to target resistance gene fragments.

Lydia Mapstone

MSc Synthetic Biology & Biotechnology

Engineering E. coli to create our mock pathogen testing platform and engineering the lytic T4 phage using BRED.

Yuri Matsueda

MSc Biotechnology

Engineering the lysogenic P1 phage with a CRISPR system to target resistance gene fragments.

Anton Puzorjov

MSc Bioinformatics

Building a model of bacteria-phage interactions in two-step re-sensitisation combining both lysogenic and lytic phages.

Yating Wang

MSc Drug Discovery & Translational Biology

Engineering the lysogenic phage P1 with a CRISPR system to target resistance gene fragments.


Owen Yeung

MSc Synthetic Biology & Biotechnology

Engineering the lysogenic lambda phage with a CRISPR system to target resistance gene fragments.

What should this page have?
  • Chronological notes of what your team is doing.
  • Brief descriptions of daily important events.
  • Pictures of your progress.
  • Mention who participated in what task.
Inspiration

You can see what others teams have done to organize their notes: